Search for Clinical Trial Results

Sponsored By

Lipidoses - 55 Studies Found

Status Study
Recruiting Study Name: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Condition: Neutral Lipid Storage Disease
Date: 2016-08-04
Completed Study Name: The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Date: 2012-01-16
Interventions: Drug: Fibrate treatment Patients will receive a dosage of 400mg Bezafibrate every day during 28 weeks
Recruiting Study Name: Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency
Condition: Sphingomyelin Lipidosis
Date: 2014-11-07
Interventions: Drug: Olipudase alfa Pharmaceutical form: powder for concentrate for solution for infusion Route of admi
Recruiting Study Name: A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency
Condition: Sphingomyelin Lipidosis
Date: 2013-11-26
Interventions: Drug: GZ402665 Pharmaceutical form: Powder for concentrate
Recruiting Study Name: Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency
Condition: Sphingomyelin Lipidosis
Date: 2013-11-26
Interventions:
  • Drug: placebo (saline)

Recruiting Study Name: Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Condition:
  • Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)
  • Neutral Lipi
    Date: 2016-07-06
    Interventions: Dietary Supplement: CNT-02 Each subject will take 2.0g of the investigational product orally 3 times a d
Recruiting Study Name: Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
Condition: Lipoidosis
Date: 2002-09-21
Completed Study Name: SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
Condition: Lipoidosis
Date: 2002-09-10
Interventions: Drug: SCH-58235
Recruiting Study Name: International Collaborative Gaucher Group (ICGG) Gaucher Registry
Condition:
  • Gaucher Disease
  • Cerebroside Lipidosis Syndrome
  • Gaucher Disease Type I
  • Cerebroside Lipidosis Syndrome
  • Date: 2006-08-15
    Interventions: Drug: Cerezyme (imiglucerase for injection)
Next >>>